Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 3
1959 1
1966 3
1967 3
1969 1
1970 2
1974 3
1975 2
1976 4
1977 1
1978 3
1980 2
1981 4
1982 7
1983 12
1984 6
1985 2
1986 7
1987 9
1988 7
1989 16
1990 8
1991 13
1992 14
1993 23
1994 23
1995 43
1996 46
1997 49
1998 54
1999 65
2000 70
2001 67
2002 76
2003 116
2004 127
2005 166
2006 207
2007 246
2008 305
2009 334
2010 353
2011 407
2012 528
2013 666
2014 718
2015 733
2016 797
2017 843
2018 910
2019 1160
2020 1341
2021 1461
2022 1709
2023 1775
2024 1993
2025 1082

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16,632 results

Results by year

Filters applied: . Clear all
Page 1
Unintrusive multi-cancer detection by circulating cell-free DNA methylation sequencing (THUNDER): development and independent validation studies.
Gao Q, Lin YP, Li BS, Wang GQ, Dong LQ, Shen BY, Lou WH, Wu WC, Ge D, Zhu QL, Xu Y, Xu JM, Chang WJ, Lan P, Zhou PH, He MJ, Qiao GB, Chuai SK, Zang RY, Shi TY, Tan LJ, Yin J, Zeng Q, Su XF, Wang ZD, Zhao XQ, Nian WQ, Zhang S, Zhou J, Cai SL, Zhang ZH, Fan J. Gao Q, et al. Among authors: fan j. Ann Oncol. 2023 May;34(5):486-495. doi: 10.1016/j.annonc.2023.02.010. Epub 2023 Feb 26. Ann Oncol. 2023. PMID: 36849097 Free article.
The secreted micropeptide C4orf48 enhances renal fibrosis via an RNA-binding mechanism.
Yang J, Zhuang H, Li J, Nunez-Nescolarde AB, Luo N, Chen H, Li A, Qu X, Wang Q, Fan J, Bai X, Ye Z, Gu B, Meng Y, Zhang X, Wu D, Sia Y, Jiang X, Chen W, Combes AN, Nikolic-Paterson DJ, Yu X. Yang J, et al. Among authors: fan j. J Clin Invest. 2024 Apr 16;134(10):e178392. doi: 10.1172/JCI178392. J Clin Invest. 2024. PMID: 38625739 Free PMC article.
Multimodule characterization of immune subgroups in intrahepatic cholangiocarcinoma reveals distinct therapeutic vulnerabilities.
Lin J, Dai Y, Sang C, Song G, Xiang B, Zhang M, Dong L, Xia X, Ma J, Shen X, Ji S, Zhang S, Wang M, Fang H, Zhang X, Wang X, Zhang B, Zhou J, Fan J, Zhou H, Gao D, Gao Q. Lin J, et al. Among authors: fan j. J Immunother Cancer. 2022 Jul;10(7):e004892. doi: 10.1136/jitc-2022-004892. J Immunother Cancer. 2022. PMID: 35863823 Free PMC article.
Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study.
Shi GM, Huang XY, Wu D, Sun HC, Liang F, Ji Y, Chen Y, Yang GH, Lu JC, Meng XL, Wang XY, Sun L, Ge NL, Huang XW, Qiu SJ, Yang XR, Gao Q, He YF, Xu Y, Sun J, Ren ZG, Fan J, Zhou J. Shi GM, et al. Among authors: fan j. Signal Transduct Target Ther. 2023 Mar 17;8(1):106. doi: 10.1038/s41392-023-01317-7. Signal Transduct Target Ther. 2023. PMID: 36928584 Free PMC article. Clinical Trial.
16,632 results
You have reached the last available page of results. Please see the User Guide for more information.